Beta Drugs Ltd

NSE :BETA BSE :535022 Sector : Pharmaceuticals

Buy, Sell or Hold BETA? Ask The Analyst

BSE

prev close

OPEN PRICE

bid price (qty)

offer price (qty)

volume

Today's low / high

52 WK low / high

NSE

prev close

open price

bid price (qty)

offer price (qty)

volume

Today's' low / high

52 WK low / high

25 Apr
1345.00
(-2.11%)

24 Apr
1374.00
(3.29%)

23 Apr
1330.25
(-4.04%)

22 Apr
1386.20
(-0.88%)

19 Apr
1398.50
(1.34%)

18 Apr
1379.95
(1.85%)

16 Apr
1354.85
(4.46%)

15 Apr
1297.00
(-0.38%)

12 Apr
1302.00
(-0.20%)

10 Apr
1304.65
(-0.84%)

09 Apr
1315.75
(-1.15%)

08 Apr
1331.10
(-3.54%)

05 Apr
1380.00
(-1.08%)

04 Apr
1395.05
(2.81%)

03 Apr
1356.90
(3.09%)

02 Apr
1316.20
(3.64%)

01 Apr
1270.00
(2.94%)

28 Mar
1233.75
(0.17%)

27 Mar
1231.65
(1.12%)

26 Mar
1218.00
(-2.17%)

22 Mar
1245.00
(-0.80%)

Price Chart Historical Data Technical Chart

Technical Analysis

Short Term Investors

Bullish

Medium Term Investors

Very Bullish

Long Term Investors

Very Bullish

Moving Averages

5 DMA

Bearish

1366.79

10 DMA

Bearish

1347.24

20 DMA

Bullish

1326.04

50 DMA

Bullish

1283.43

100 DMA

Bullish

1341.76

200 DMA

Bullish

1149.77

Intraday Support and Resistance
(Based on Pivot Points) |

Updated On Apr 25, 2024 04:00 PM For Next Trading Session

Pivots	Classic	Fibonacci	Camarilla	Woodie	DM
R3	1428.34	1411.67	1358.75	-	-
R2	1411.67	1392.57	1354.17	1407.5	-
R1	1378.34	1380.77	1349.58	1370	1395
P	1361.67	1361.67	1361.67	1357.5	1370
S1	1328.34	1342.57	1340.42	1320	1345
S2	1311.67	1330.77	1335.83	1307.5	-
S3	1278.34	1311.67	1331.25	-	-

Key Metrics

Shareholding Pattern

	66.73%	Total Promoter Holding

	0%	Mutual Fund Holdings

	0.32%	FIIs

	32.92%	Non Institution

	0%	Insurance Companies

	0%	Custodians

	0.03%	Other Parties

Shareholding History

Beta Drugs Ltd Quaterly Results


INCOME
PROFIT
EPS

Beta Drugs Ltd Quaterly Results


INCOME
PROFIT
EPS

Profit & Loss (Figures in Rs. Crores)

Consolidated
Standalone

Beta Drugs Ltd Profit & Loss

	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
INCOME	51.49	69.97	92.07	118.39	186.35	232.57
PROFIT	6.76	8.04	9.44	11.72	24.83	30.72
EPS	7.82	9.3	9.79	12.2	25.82	31.95

Beta Drugs Ltd Profit & Loss

	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
INCOME	1.36	0.37	26.6	41.22	51.49	61.04	65.54	81.45	124.85	162.08
PROFIT	0.02	-0.11	1.13	4.27	6.76	7.71	7.1	6.98	14.25	18.82
EPS	21.7	0	11.23	42.27	7.82	8.92	7.39	7.26	14.82	19.57

Balance Sheet (Figures in Rs. Crores)

Consolidated
Standalone

	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018
SOURCES OF FUNDS :
Share Capital	9.61	9.61	9.61	9.61	8.65	8.65
Reserves Total	113.27	82.73	59	47.5	32.27	24.23
Total Shareholders Funds	122.88	92.34	68.61	57.11	40.92	32.88
Secured Loans	20.33	20.6	17.46	22.54	19.97	7.5
Unsecured Loans	0	0	0	0.03	0	0
Total Debt	20.33	20.6	17.46	22.57	19.97	7.5
Other Liabilities	5.55	4.71	4.46	3.1	2.27	0.43
Total Liabilities	148.76	117.65	90.53	82.78	63.16	40.81
APPLICATION OF FUNDS :
Gross Block	99.37	82.17	61.14	58.29	25.38	18.06
Less: Accumulated Depreciation	36.61	27.22	21.17	14.46	7.71	4.87
Net Block	62.76	54.95	39.97	43.83	17.67	13.19
Capital Work in Progress	0	0	2.81	0.08	14.69	1.35
Investments	0.78	0.78	0.78	0.35	0.35	0
Inventories	30.62	22.48	16.04	12.35	9.53	2.8
Sundry Debtors	62.72	45.18	33.88	31.93	25.03	14.44
Cash and Bank Balance	19.16	17.32	10.42	5.39	3.3	11.91
Loans and Advances	15.18	11.97	7.7	6.37	5.09	3.17
Total Current Assets	127.69	96.96	68.04	56.04	42.95	32.32
Current Liabilities	45.49	36.56	25.55	23.19	18.64	8.3
Provisions	4.17	3.63	1.42	1.2	0.74	0.33
Total Current Liabilities & Provisions	49.66	40.19	26.96	24.4	19.38	8.63
Net Current Assets	78.03	56.77	41.07	31.64	23.57	23.7
Deferred Tax Assets	1.2	0.68	0.65	0.17	0.29	0
Deferred Tax Liability	0	0	0	0	0.15	0.15
Net Deferred Tax	1.2	0.68	0.65	0.17	0.14	-0.15
Other Assets	6	4.48	5.26	6.72	6.74	2.72
Total Assets	148.77	117.67	90.54	82.78	63.16	40.8
Contingent Liabilities	1.51	0	0	0.73	0	0

	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014
SOURCES OF FUNDS :
Share Capital	9.61	9.61	9.61	9.61	8.65	8.65	1.01	1.01	1.01	0.01
Reserves Total	86.64	67.85	53.8	46.83	31.95	24.23	5.06	1.19	0.06	0.17
Total Shareholders Funds	96.25	77.46	63.41	56.44	40.6	32.88	6.07	2.2	1.07	0.18
Secured Loans	5.95	6.84	5.19	8.88	6.09	7.5	5.85	5.37	1.99	0.63
Unsecured Loans	0	0	0	0.03	1.79	0	2.36	2.97	2.78	0.34
Total Debt	5.95	6.84	5.19	8.91	7.88	7.5	8.21	8.34	4.77	0.97
Other Liabilities	2.59	2.44	1.82	0.86	0.58	0.43	0.25	0.06	0	0
Total Liabilities	104.79	86.74	70.42	66.21	49.06	40.81	14.53	10.6	5.84	1.15
APPLICATION OF FUNDS :
Gross Block	59.84	53.86	43.15	41.54	19.41	18.06	11.12	9.1	1.07	1.07
Less : Accumulated Depreciation	25.07	19.81	15.14	9.87	7.29	4.87	3.02	1.76	0.52	0.42
Net Block	34.77	34.05	28.01	31.67	12.12	13.19	8.1	7.34	0.55	0.65
Capital Work in Progress	0	0	1.9	0.08	14.69	1.35	0	0	5.71	0
Investments	6.55	6.54	6.54	6.12	1.61	0	0	0	0	0
Inventories	13.66	8.47	7.7	6.1	6.41	2.8	2.4	2.86	1.28	0.29
Sundry Debtors	43.59	31.35	20.81	20.91	17.33	14.44	10.51	4.4	0.08	0.29
Cash and Bank Balance	17.79	15.58	8.27	4.16	2.92	11.91	0.14	0.13	0.06	0.01
Loans and Advances	9.95	7.35	6.78	6	4.73	3.17	2.05	0.41	0.27	0.12
Total Current Assets	85	62.76	43.55	37.17	31.39	32.32	15.11	7.8	1.69	0.7
Current Liabilities	26.31	22.22	15.23	15.42	15.01	8.3	7.74	4.57	2.17	0.2
Provisions	2.94	1.94	0.57	0.56	0.58	0.33	0.86	0.03	0	0
Total Current Liabilities & Provisions	29.25	24.16	15.81	15.98	15.59	8.63	8.6	4.6	2.17	0.2
Net Current Assets	55.75	38.6	27.74	21.19	15.8	23.7	6.5	3.2	-0.48	0.5
Deferred Tax Assets	0.89	0.6	0.37	0	0.25	0	0	0	0	0
Deferred Tax Liability	0	0	0	0.03	0.15	0.15	0.08	0	0	0
Net Deferred Tax	0.89	0.6	0.37	-0.03	0.1	-0.15	-0.08	0	0	0
Other Assets	6.83	6.94	5.86	7.18	4.74	2.72	0	0.07	0.07	0.01
Total Assets	104.79	86.74	70.42	66.21	49.06	40.8	14.53	10.61	5.84	1.15
Contingent Liabilities	0.74	0	0	0	0	0	0	0	0	0

Cash Flow (Figures in Rs. Crores)

Consolidated
Standalone

Cash from Operating Activity 23.38

Net Profit before Tax and Extr...	41.06
Depreciation	10.41
Interest (Net)	1.75
Total Adjustments (PBT and Ext...	2.02
Operating Profit before Workin...	43.08
Trade and 0ther Receivables	-17.54
Inventories	-8.14
Trade Payables	8.29
Loans and Advances	-1.61
Total Adjustments (OP before W...	-19.69
Cash Generated from/(used in) ...	23.38
Cash Flow before Extraordinary...	23.38
Net Cash from Operating Activi...	23.38

Cash from Investing Activity -19.07

Purchased of Fixed Assets	-18.21
Interest Received	0.66
Net Cash used in Investing Act...	-19.07

Cash from Financing Activity -2.47

Proceed from Short Tem Borrowi...	4.31
Of the Long Tem Borrowings	-4.37
Interest Paid	-2.41
Net Cash used in Financing Act...	-2.47

Cash from Operating Activity 10.23

Net Profit before Tax and Extr...	25.21
Depreciation	6.19
Interest (Net)	-0.15
Total Adjustments (PBT and Ext...	0.42
Operating Profit before Workin...	25.63
Trade and 0ther Receivables	-12.24
Inventories	-5.19
Trade Payables	3.55
Loans and Advances	-0.95
Total Adjustments (OP before W...	-15.41
Cash Generated from/(used in) ...	10.23
Cash Flow before Extraordinary...	10.23
Net Cash from Operating Activi...	10.23

Cash from Investing Activity -5.82

Purchased of Fixed Assets	-6.91
Purchase of Investments	-0.01
Interest Received	0.99
Net Cash used in Investing Act...	-5.82

Cash from Financing Activity -2.19

Of the Long Tem Borrowings	-1.36
Interest Paid	-0.84
Net Cash used in Financing Act...	-2.19

Company Details

Registered Office
Address	Village Nandpur,
City	Baddi
State	Himachal Pradesh
Pin Code	174101
Tel. No.	91-1795-236196
Fax. No.
Email	info@betadrugslimited.com
Internet	http://www.betadrugslimited.com

Registrars
Address	Village Nandpur
City	Baddi
State	Himachal Pradesh
Pin Code	174101
Tel. No.	91-1795-236196
Fax. No.
Email	info@betadrugslimited.com
Internet	http://www.betadrugslimited.com

Management
Name	Designation
Balwant Singh.	Whole-time Director
Varun Batra	Joint Managing Director
Rahul Batra	Chairperson & M D
Manmohan Khanna	Independent Director
Rohit Parti	Independent Director
Rajni Brar	Company Sec. & Compli. Officer
Seema Chopra	Whole-time Director
Ashutosh Shukla	Whole-time Director

MARKET TODAY

PRODUCTS

SUPPORT

LEGAL & PRIVACY

MAGAZINES

Stocks: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

Data is a real-time snapshot *Data is delayed by at least 15 minutes. StockFact, Market Action Data and Analysis. Data Provider CMOTS Infotech.

Disclaimer : There is no guarantee of profits or no exceptions from losses. The investment advice provided is solely the personal views of the research team. Equitypandit will not accept any liability for loss or damage as a result of reliance on the information contained within this website including data, quotes, charts and buy/sell signals. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. Therefore, Equitypandit doesn't bear any responsibility for any trading losses you might incur as a result of using this data.

Beta Drugs Ltd

Buy, Sell or Hold BETA? Ask The Analyst

BSE

NSE

Price Chart Historical Data Technical Chart

Technical Analysis

Short Term Investors

Bullish

Medium Term Investors

Very Bullish

Long Term Investors

Very Bullish

Moving Averages

5 DMA

Bearish

10 DMA

Bearish

20 DMA

Bullish

50 DMA

Bullish

100 DMA

Bullish

200 DMA

Bullish

Intraday Support and Resistance (Based on Pivot Points) |

Key Metrics

Shareholding Pattern

Shareholding History

Quarterly Result (Figures in Rs. Crores)

Beta Drugs Ltd Quaterly Results

Beta Drugs Ltd Quaterly Results

Profit & Loss (Figures in Rs. Crores)

Beta Drugs Ltd Profit & Loss

Beta Drugs Ltd Profit & Loss

Balance Sheet (Figures in Rs. Crores)

Cash Flow (Figures in Rs. Crores)

Company Details

Registered Office

Registrars

Management

MARKET TODAY

PRODUCTS

SUPPORT

LEGAL & PRIVACY

MAGAZINES

Intraday Support and Resistance
(Based on Pivot Points) |